Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38370
CAS Number:
68291-97-4
Zonisamida
Purity:
≥ 98 % (HPLC)
Synonym(s):
1,2-Benzisoxazol-3-metanosulfonamida
Documents
$101.45 /200 mg
Tamaño
Request Bulk Quote
Información del producto

Zonisamide is a versatile sulfonamide compound recognized for its efficacy in the treatment of epilepsy and other neurological disorders. This compound exhibits a unique mechanism of action, which includes the inhibition of voltage-gated sodium channels and the modulation of neurotransmitter release, making it a valuable option for managing seizure disorders. Its ability to cross the blood-brain barrier allows for effective therapeutic concentrations in the central nervous system, providing significant benefits for patients with refractory epilepsy.

In addition to its primary use in neurology, Zonisamide has shown potential in weight management and the treatment of mood disorders, expanding its relevance in various therapeutic areas. Researchers and healthcare professionals appreciate its favorable side effect profile compared to other antiepileptic drugs, making it a preferred choice in polytherapy settings. With ongoing studies exploring its broader applications, Zonisamide stands out as a promising compound in both clinical and research environments.

Número CAS
68291-97-4
Fórmula molecular
C8H8N2O3S
Peso molecular
212.22
Número MDL
MFCD00865316
Punto de fusión
163 - 167 °C
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
68291-97-4
Fórmula molecular
C8H8N2O3S
Peso molecular
212.22
Número MDL
MFCD00865316
Punto de fusión
163 - 167 °C
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Zonisamide is widely utilized in research focused on:

  • Epilepsy Treatment: Commonly prescribed as an anticonvulsant, it helps manage seizures in patients with epilepsy, offering a valuable alternative for those who do not respond to other medications.
  • Weight Management: Research indicates its potential in weight loss therapies, as it may help reduce appetite and promote metabolic changes, making it beneficial for obesity treatment.
  • Parkinson's Disease: Studies suggest that it may have neuroprotective effects, providing a supplementary treatment option for patients suffering from Parkinson's disease.
  • Chronic Pain Management: Zonisamide is being explored for its analgesic properties, offering potential relief for patients with chronic pain conditions, enhancing their quality of life.
  • Research in Neurodegenerative Disorders: Its unique mechanism of action is being investigated for broader applications in neurodegenerative diseases, potentially leading to new therapeutic strategies.

Citas